Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder

Endocrinology

Volumn 145, Issue 9, 2004, Pages 4330-4343

  Jesmin, Subrina ^b   Togashi, Hiroko ^b   Sakuma, Ichiro ^a   Mowa, Chishimba N ^b   Ueno, Ken Ichi ^b   Yamaguchi, Taku ^b   Yoshioka, Mitsuhiro ^b   Kitabatake, Akira ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; ANGIOGENIC FACTOR; AROMATASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLUTAMIDE; PROTEIN KINASE B; RECEPTOR BLOCKING AGENT; SEX HORMONE; TESTOSTERONE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANDROGEN METABOLISM; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN BLOOD FLOW; CAPILLARY DENSITY; CASTRATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; ESSENTIAL HYPERTENSION; ESTROGEN SYNTHESIS; FRONTAL CORTEX; HORMONE BLOOD LEVEL; JUVENILE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RAT STRAIN; STROKE; UPREGULATION;

ANIMALS; AROMATASE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAPILLARIES; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FRONTAL LOBE; GONADAL STEROID HORMONES; HYPERTENSION; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TESTOSTERONE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 4344684088     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0487     Document Type: Article

References (81)

1. American Psychiatric Association 1994 Attention-deficit and disruptive behavior disorders. In: Diagnostic and statistical manual of mental disorders, DSM-IV. Washington, DC: American Psychiatric Association; 78-85
2. Castellanos FX, Giedd JN, Eckburg P, Marsh WL, Vaituzis AC, Kaysen D, Hamburger SD, Rapoport JL 1994 Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder. Am J Psychiatry 151:1791-1796
3. Taylor E 1998 Clinical foundations of hyperactivity research. Behav Brain Res 94:11-24
4. Lahey BB, Applegate B, McBurnett K, Biederman J, Greenhill L, Hynd GW, Berkley RA, Newcorn J, Jensen P, Richters J, Garfinkel B, Kerdyk L, Frick PJ, Ollendick T, Perez D, Hart EL, Waldman I, Shaffer D 1994 DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents. Am J Psychiatry 151:1673-1685
5. Lou HC, Henriksen L, Bruhn P 1984 Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 41:825-829
6. Zametkin AJ, Liotta W 1998 The neurobiology of attention-deficit/ hyperactivity disorder. J Clin Psychiatry 59:17-23
7. Castellanos FX 1997 Toward a pathophysiology of attention-deficit/ hyperactivity disorder. Clin Pediatr (Phila) 36:381-393
8. Giedd JN, Blumenthal J, Molloy E, Castellanos FX 2001 Brain imaging of attention deficit/hyperactivity disorder. Ann NY Acad Sci 931:33-49
9. Gustafsson P, Thernlund G, Ryding E, Rosen I, Cederblad M 2000 Associations between cerebral blood flow measured by single photon emission computed tomography (SPECT), electroencephalogram (EEG), behaviour symptoms, cognition and neurological soft signs in children with attention-deficit hyperactivity disorder. Acta Paediatr 89:830-835
10. Kim BN, Lee JS, Shin MS, Cho SC, Lee DS 2002 Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder. Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci 252:219-225
11. Spalletta G, Pasini A, Pau F, Guido G, Menghini L, Caltagirone C 2001 Prefrontal blood flow dysregulation in drug naive ADHD children without structural abnormalities. J Neural Transm 108:1203-1216
12. Becker JB 1999 Gender differences and influences of reproductive hormones on dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 64:803-812
13. McEwen BS, Gould E, Orcinik M, Weiland NG, Wooley CS 1995 Oestrogens and the structural and functional plasticity of neurons: implications for memory, ageing and neurodegenerative processes. In: Goode J, ed. The non-reproductive actions of sex steroids. Ciba Foundation Symposium. London: John Wiley & Sons, Inc.; 191:52-73
14. McEwen BS, Alves SH 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
15. King JA, Barkley RA, Delville Y, Ferris CF 2000 Early androgen treatment decreases cognitive function and catecholamine innervation in an animal model of ADHD. Behav Brain Res 107:35-43
16. Comings DE, Chen C, Wu S, Muhleman D 1999 Association of the androgen receptor gene (AR) with ADHD and conduct disorder. Neuroreport 10:1589-1592
17. King JA, Kelly TA, Delville Y 2000 Adult levels of testosterone alter catecholamine innervation in an animal model of attention-deficit hyperactivity disorder. Neuropsychobiology 42:163-168
18. Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H, Chiu F, Wang E, Farwell K, Darakjy S, Baker R, Dietz G, Saucier G, MacMurray JP 2000 Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 58:31-40
19. Sawada H, Shimohama S 2000 Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 24:143-147
20. Feng J, Yan J, Michaud S, Craddock N, Jones IR, Cook Jr EH, Goldman D, Heston LL, Peltonen L, Delisi LE, Sommer SS 2001 Scanning of estrogen receptor α (ERα) and thyroid hormone receptor α (TRα) genes in patients with psychiatric diseases: four missense mutations identified in ERα gene. Am J Med Genet 105:369-374
21. Biederman J, Faraone SV 2002 Current concepts on the neurobiology of attention-deficit/hyperactivity disorder. J Atten Disord 6(Suppl 1):S7-S16
22. Carlsson ML 2001 On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 25:5-26
23. Prohovnik I, Arnold SE, Smith G, Lucas LR 1997 Physostigmine reversal of scopolamine-induced hypofrontality. J Cereb Blood Flow Metab 17:220-228
24. Mack CM, McGivern RF, Hyde LA, Denenberg VH 1996 Absence of postnatal testosterone fails to demasculinize the male rat's corpus callosum. Brain Res Dev Brain Res 95:252-255
25. Arnold AP, Breedlove SM 1985 Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm Behav 19:469-498
26. Hernandez L, Gonzalez L, Murzi E, Paez X, Gottberg E, Baptista T 1994 Testosterone modulates mesolimbic dopaminergic activity in male rats. Neurosci Lett 171:172-174
27. Stewart J, Rajabi H 1994 Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat. Brain Res 646:157-160
28. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ 1999 Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354:2132-2133
29. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K 2000 Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285:107-110
30. Arnold A, Gorski R 1984 Gonadal steroid induction of structural sex differences in the central nervous system. Annu Rev Neurosci 7:413-442
31. MacLusky N, Naftolin F 1981 Sexual differentiation of the central nervous system. Science 211:1294-1303
32. Baum MJ, Brand T, Ooms M, Vreeburg JT, Slob AK 1988 Immediate postnatal rise in whole body androgen content in male rats: correlation with increased testicular content and reduced body clearance of testosterone. Biol Reprod 38:980-986
33. Pang SF, Tang F 1984 Sex differences in the serum concentrations of testosterone in mice and hamsters during their critical periods of neural sexual differentiation. J Endocrinol 100:7-11
34. Kim BN, Lee JS, Cho SC, Lee DS 2001 Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder. Yonsei Med J 42:19-29
35. Ueno K, Togashi H, Mori K, Matsumoto M, Ohashi S, Hoshino A, Fujita T, Saito H, Minami M, Yoshioka M 2002 Behavioural and pharmacological relevance of stroke-prone spontaneously hypertensive rats as an animal model of a developmental disorder. Behav Pharmacol 13:1-13
36. Ueno K, Togashi H, Matsumoto M, Ohashi S, Saito H, Yoshioka M 2002 α4β2 Nicotinic acetylcholine receptor activation ameliorates impairment of spontaneous alternation behavior in stroke-prone spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder. J Pharmacol Exp Ther 302:95-100
37. Agrawal R, Conway GS, Sladkevicius P, Payne NN, Bekir J, Campbell S, Tan SL, Jacobs HS 1999 Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clin Endocrinol (Oxf) 50:101-106
38. Haggstrom S, Lissbrant IF, Bergh A, Damber JE 1999 Testosterone induces vascular endothelial growth factor synthesis in the ventral prostate in castrated rats. J Urol 161:1620-1625
39. Albrecht ED, Pepe GJ 2003 Steroid hormone regulation of angiogenesis in the primate endometrium. Front Biosci 8:d416-d429
40. Storment JM, Meyer M, Osol G 2003 Estrogen augments the vasodilatory effects of vascular endothelial growth factor in the uterine circulation of the rat. Am J Obstet Gynecol 183:449-453
41. Virgintino D, Errede M, Robertson D, Girolamo F, Masciandaro A, Bertossi M 2003 VEGF expression is developmentally regulated during human brain angiogenesis. Histochem Cell Biol 119:227-232
42. Haigh JJ, Morelli PI, Gerhardt H, Haigh K, Tsien J, Damert A, Miquerol L, Muhlner U, Klein R, Ferrara N, Wagner EF, Betsholtz C, Nagy A 2003 Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. Dev Biol 262:225-241
43. Luthman J, Fredriksson A, Lewander T, Jonsson G, Archer T 1989 Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatment. Psychopharmacology (Berl) 99:550-557
44. Giros B, Jaber M, Jones SR, Wighlman RM, Caron MG 1996 Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612
45. Sagvolden T 2000 Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 24:31-39
46. Sagvolden T, Berger DF 1996 An animal model of attention deficit disorders: the female shows more behavioral problems and is more impulsive than the male. Eur Psychologist 1:113-122
47. Wultz B, Sagvolden T, Moser EI, Moser M-B 1990 The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol 53:88-102
48. Nakamura K, Shirane M, Koshikawa N 2001 Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats. Brain Res 897:82-92
49. Togashi H, Kimura S, Matsumoto M, Yoshioka M, Minami M, Saito H 1996 Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke 27:520-525
50. Togashi H, Minami M, Bando Y, Koike Y, Shimamura K, Saito H 1982 Effects of clonidine and guanfacine on drinking and ambulation in spontaneously hypertensive rats. Pharmacol Biochem Behav 17:519-522
51. Togashi H, Matsumoto M, Yoshioka M, Hirokami M, Minami M, Saito H 1994 Neurochemical profiles in cerebrospinal fluid of stroke-prone spontaneously hypertensive rats. Neurosci Lett 166:117-120
52. Togashi H, Ueno K, Jesmin S, Sakuma I, Matsumoto M, Inoue Y, Yoshioka M, Effects of gonadectomy and gonadal hormone replacement on short-term memory impairment in an animal model of attention-deficit /hyperactivity disorder. Proc 33rd Annual Meeting of the Society for Neuroscience, New Orleans, Louisiana, 2003 (Abstract 668.4)
53. Jesmin S, Hattori Y, Sakuma I, Liu MY, Mowa CN, Kitabatake A 2003 Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 23:181-189
54. Jesmin S, Sakuma I, Hattori Y, Kitabatake A 2002 In vivo estrogen manipulations on coronary capillary network and angiogenic molecule expression in middle-aged female rats. Arterioscler Thromb Vasc Biol 22:1591-1597
55. Jesmin S, Mowa CN, Matsuda N, Salah-Eldin AE, Togashi H, Sakuma I, Hattori Y, Kitabatake A 2002 Evidence for a potential role of estrogen in the penis: detection of estrogen receptor-α and -β messenger ribonucleic acid and protein. Endocrinology 143:4764-4774
56. Jesmin S, Sakuma I, Salah-Eldin A, Nonomura K, Hattori Y, Kitabatake A 2003 Diminished penile expression of vascular endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction in diabetes. J Mol Endocrinol 31:401-418
57. Jesmin S, Hattori Y, Sakuma I, Mowa CN, Kitabatake A 2002 Role of ANG II in coronary capillary angiogenesis at the insulin-resistant stage of a NIDDM rat model. Am J Physiol Heart Circ Physiol 283:H1387-H1397
58. Mowa CN, Iwanaga T 2001 Expression of estrogen receptor-α and -β mRNAs in the male reproductive system of the rat as revealed by in situ hybridization. J Mol Endocrinol 26:165-174
59. Lauber ME, Lichtensteiger W 1994 Pre- and postnatal ontogeny of aromatase cytochrome P450 messenger ribonucleic acid expression in the male rat brain studied by in situ hybridization. Endocrinology 135:1661-1668
60. Znamensky V, Akama KT, McEwen BS, Milner TA 2003 Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci 23:2340-2347
61. Joo F 1985 The blood-brain barrier in vitro: ten years of research on microvessels isolated from the brain. Neurochem Int 7:1-25
62. Yamori Y, Horie R 1977 Developmental course of hypertension and regional cerebral blood flow in stroke-prone spontaneously hypertensive rats. Stroke 8:456-461
63. Ogunshola OO, Stewart WB, Mihalcik V, Solli T, Madri JA, Ment LR 2000 Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res Dev Brain Res 119:139-153
64. Bar T 1980 The vascular system of the cerebral cortex. Adv Anat Embryol Cell Biol 59:1-62
65. Robertson PL, Dubois M, Bowman PD, Goldstein GW 1985 Angiogenesis in developing rat-brain - an in vivo and in vitro study. Dev Brain Res 23:219-223
66. Louissaint Jr A, Rao S, Leventhal C, Goldman SA 2002 Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 34:945-960
67. Kanda N, Watanabe S 2002 17β-Estradiol enhances vascular endothelial growth factor production and dihydrotestosterone antagonizes the enhancement via the regulation of adenylate cyclase in differentiated THP-1 cells. J Invest Dermatol 118:519-529
68. Frye CA, Rhodes ME, Walf A, Harney JP 2002 Testosterone enhances aggression of wild-type mice but not those deficient in type 15α-reductase. Brain Res 948:165-170
69. Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA 2003 Update on estrogen signaling. FEBS Lett 546:17-24
70. Labrie F, Luu-The V, Labrie C, Simard J 2001 DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 22:185-212
71. Hackenberg R, Turgetto I, Filmer A, Schulz KD 1993 Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3β, 17β-diol in human mammary cancer cells. J Steroid Biochem Mol Biol 46:597-603
72. Ho SM, Ofner P 1986 Prostatic cytosol binding of 5α-androstane- 3β, 17β-diol and estradiol-17β. Steroids 47:21-34
73. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870
74. Verjan HL, Eik-Nes KB 1977 Comparison of effects of C19 (androstene or androstane) steroids on serum gonadotrophin concentrations and on accessory reproductive organ weights in gonadectomized, adult male rats. Acta Endocrinol 84:829-841
75. McEwen B 2002 Estrogen actions throughout the brain. Recent Prog Horm Res 57:357-384
76. Ogawa S, Lubahn DB, Korach KS, Pfaff DW 1997 Behavioral effects of estrogen receptor gene disruption in male mice. Proc Natl Acad Sci USA 94:1476-1481
77. Osterlund MK, Keller E, Hurd YL 2000 The human forebrain has discrete estrogen receptor α messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 95:333-342
78. Ogawa S, Washburn TF, Taylor J, Lubahn DB, Korach KS, Pfaff DW 1998 Modifications of testosterone-dependent behaviors by estrogen receptor-α gene disruption in male mice. Endocrinology 139:5058-5069
79. Nomura M, Durbak L, Chan J, Smithies O, Gustafsson JA, Korach KS, Pfaff DW, Ogawa S 2002 Genotype/age interactions on aggressive behavior in gonadally intact estrogen receptor β knockout (βERKO) male mice. Horm Behav 41:288-296
80. Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW 2003 Estrogen increases locomotor activity in mice through estrogen receptor α: specificity for the type of activity. Endocrinology 144:230-239
81. Clancy B, Darlington RB, Finlay BL 2001 Translating developmental time across mammalian species. Neuroscience 105:7-17